PDK1 and neoplasm: Tumours demonstrate a growth advantage through a shift in metabolism, specifically, from oxidative phosphorylation to glycolytic metabolism, which is driven by HIF-1–pyruvate dehydrogenase kinase 1 (PDK1) [127].